Circulation Research. 2004;94:960-966
Published online before print February 19, 2004, doi: 10.1161/01.RES.0000122392.33172.09
Published online before print February 19, 2004, doi: 10.1161/01.RES.0000122392.33172.09
© 2004 American Heart Association, Inc.
Integrative Physiology |
Opioid-Induced Cardioprotection Occurs via Glycogen Synthase Kinase ß Inhibition During Reperfusion in Intact Rat Hearts
From the Medical College of Wisconsin, Department of Pharmacology and Toxicology, Milwaukee, Wis.
Correspondence to Garrett J. Gross, PhD, Medical College of Wisconsin, Department of Pharmacology and Toxicology, 8701 Watertown Plank Rd, Milwaukee, WI 53226. E-mail ggross{at}mcw.edu
Glycogen synthase kinase (GSK) inhibition produced by ischemic preconditioning has been previously shown to be regulated through phosphatidylinositol-3 kinase (PI3K). Therefore, we determined whether opioid-induced cardioprotection (OIC) occurs during reperfusion by altering GSK phosphorylation through PI3K and target of rapamycin (TOR). Furthermore, we determined if selective GSK inhibitors, SB216763(SB21) or SB415286(SB41), emulate OIC. Rats were treated with the nonselective opioid agonist, morphine (MOR, 0.3 mg/kg), the 
-selective opioid agonist BW373U86 (BW, 1 mg/kg), or the GSK inhibitors, SB21 (0.6 mg/kg) or SB41(1.0 mg/kg), either 10 minutes before ischemia or 5 minutes before reperfusion. Five minutes before opioid or SB21 treatment, some rats received either the PI3K inhibitor wortmannin (15 µg/kg) or LY294002 (0.3 mg/kg) or the TOR inhibitor rapamycin (3 µg/kg). After 30 minutes of ischemia followed by 2 hours of reperfusion, infarct size was assessed. MOR, BW, SB41, and SB21 reduced infarct size compared with vehicle when administered before ischemia (42.9±2.6, 40.3±2.3, 46.6±1.6, 42.2±1.8 versus 60.0±1.1%, respectively; P<0.001) and showed similar protection when administered 5 minutes before reperfusion (43.6±2.3, 40.2±2.6, 44.8±2.8, 39.4±0.8%, respectively; P<0.001). Wortmannin, LY294002, and rapamycin were found to inhibit OIC; however, they did not abrogate SB21-induced infarct size reduction. At 5 minutes of reperfusion, both MOR and BW increased P-GSKß at Ser9 in the ischemic zone compared with vehicle (181±20, 178±15 versus 75±17 DU, respectively; P<0.05), and this effect was abrogated by prior administration of wortmannin or rapamycin in MOR-treated rats. Furthermore, no differences were seen in phosphorylation of GSK
(Ser21 or Tyr279) or phosphorylation of GSKß (Tyr216). These data indicate that OIC occurs via the phosphorylation of GSKß at Ser9 during reperfusion.
Key Words: reperfusion • glycogen synthase kinase • phosphatidylinositol-3 kinase • target of rapamycin • opioids
This article has been cited by other articles:
 |
|
 |
|
  F. N. Obame, C. Plin-Mercier, R. Assaly, R. Zini, J. L. Dubois-Rande, A. Berdeaux, and D. Morin Cardioprotective Effect of Morphine and a Blocker of Glycogen Synthase Kinase 3{beta}, SB216763 [3-(2,4-Dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via Inhibition of the Mitochondrial Permeability Transition Pore J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 252 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gomez, M. Paillard, H. Thibault, G. Derumeaux, and M. Ovize Inhibition of GSK3{beta} by Postconditioning Is Required to Prevent Opening of the Mitochondrial Permeability Transition Pore During Reperfusion Circulation, May 27, 2008; 117(21): 2761 - 2768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Zatta, H. Kin, D. Yoshishige, R. Jiang, N. Wang, J. G. Reeves, J. Mykytenko, R. A. Guyton, Z.-Q. Zhao, J. L. Caffrey, et al. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1444 - H1451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Gross, A. K. Hsu, and G. J. Gross Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1497 - H1500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Gustafsson and R. A. Gottlieb Heart mitochondria: gates of life and death Cardiovasc Res, January 15, 2008; 77(2): 334 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D.T. Costa, S. V. Pierre, M. V. Cohen, J. M. Downey, and K. D. Garlid cGMP signalling in pre- and post-conditioning: the role of mitochondria Cardiovasc Res, January 15, 2008; 77(2): 344 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Liem, H. M. Honda, J. Zhang, D. Woo, and P. Ping Past and present course of cardioprotection against ischemia- reperfusion injury J Appl Physiol, December 1, 2007; 103(6): 2129 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Jiang, A. Zatta, H. Kin, N. Wang, J. G. Reeves, J. Mykytenko, J. Deneve, Z.-Q. Zhao, R. A. Guyton, and J. Vinten-Johansen PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2845 - H2852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Pagel, J. G. Krolikowski, Y. H. Shim, S. Venkatapuram, J. R. Kersten, D. Weihrauch, D. C. Warltier, and P. F. Pratt Jr Noble Gases Without Anesthetic Properties Protect Myocardium Against Infarction by Activating Prosurvival Signaling Kinases and Inhibiting Mitochondrial Permeability Transition In Vivo Anesth. Analg., September 1, 2007; 105(3): 562 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Forster, A. Kuno, N. Solenkova, S. B. Felix, and T. Krieg The {delta}-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1604 - H1608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jang, H. Wang, J. Xi, R. A. Mueller, E. A. Norfleet, and Z. Xu NO mobilizes intracellular Zn2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes Cardiovasc Res, July 15, 2007; 75(2): 426 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujita, H. Asanuma, A. Hirata, M. Wakeno, H. Takahama, H. Sasaki, J. Kim, S. Takashima, O. Tsukamoto, T. Minamino, et al. Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H2004 - H2008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. C. Manintveld, M. te Lintel Hekkert, E. J. van den Bos, G. M. Suurenbroek, D. H. Dekkers, P. D. Verdouw, J. M. Lamers, and D. J. Duncker Cardiac effects of postconditioning depend critically on the duration of index ischemia Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1551 - H1560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Gross, A. K. Hsu, and G. J. Gross Diabetes Abolishes Morphine-Induced Cardioprotection via Multiple Pathways Upstream of Glycogen Synthase Kinase-3{beta} Diabetes, January 1, 2007; 56(1): 127 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Doukas, W. Wrasidlo, G. Noronha, E. Dneprovskaia, R. Fine, S. Weis, J. Hood, A. DeMaria, R. Soll, and D. Cheresh Phosphoinositide 3-kinase {gamma}/{delta} inhibition limits infarct size after myocardial ischemia/reperfusion injury PNAS, December 26, 2006; 103(52): 19866 - 19871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Venkatapuram, C. Wang, J. G. Krolikowski, D. Weihrauch, J. R. Kersten, D. C. Warltier, P. F. Pratt Jr, and P. S. Pagel Inhibition of Apoptotic Protein p53 Lowers the Threshold of Isoflurane-Induced Cardioprotection During Early Reperfusion in Rabbits Anesth. Analg., December 1, 2006; 103(6): 1400 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Parkitna, I. Obara, A. Wawrzczak-Bargiela, W. Makuch, B. Przewlocka, and R. Przewlocki Effects of Glycogen Synthase Kinase 3beta and Cyclin-Dependent Kinase 5 Inhibitors on Morphine-Induced Analgesia and Tolerance in Rats J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 832 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Peart and G. J. Gross Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1746 - H1753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Couvreur, L. Lucats, R. Tissier, A. Bize, A. Berdeaux, and B. Ghaleh Differential effects of postconditioning on myocardial stunning and infarction: a study in conscious dogs and anesthetized rabbits Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1345 - H1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Gross, A. K. Hsu, and G. J. Gross The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3beta Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H827 - H834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nishihara, T. Miura, T. Miki, J. Sakamoto, M. Tanno, H. Kobayashi, Y. Ikeda, K. Ohori, A. Takahashi, and K. Shimamoto Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3beta Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H748 - H755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Raphael, S. Abedat, J. Rivo, K. Meir, R. Beeri, T. Pugatsch, Z. Zuo, and Y. Gozal Volatile Anesthetic Preconditioning Attenuates Myocardial Apoptosis in Rabbits after Regional Ischemia and Reperfusion via Akt Signaling and Modulation of Bcl-2 Family Proteins J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 186 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-S. Park, H. Zhao, Y. Jang, R. A. Mueller, and Z. Xu N6-(3-Iodobenzyl)-adenosine-5'-N-methylcarboxamide Confers Cardioprotection at Reperfusion by Inhibiting Mitochondrial Permeability Transition Pore Opening via Glycogen Synthase Kinase 3beta J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 124 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shinohara, N. Takahashi, T. Ooie, M. Hara, S. Shigematsu, M. Nakagawa, H. Yonemochi, T. Saikawa, and H. Yoshimatsu Phosphatidylinositol 3-kinase-dependent activation of akt, an essential signal for hyperthermia-induced heat-shock protein 72, is attenuated in streptozotocin-induced diabetic heart. Diabetes, May 1, 2006; 55(5): 1307 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Pagel, J. G. Krolikowski, D. A. Neff, D. Weihrauch, M. Bienengraeber, J. R. Kersten, and D. C. Warltier Inhibition of glycogen synthase kinase enhances isoflurane-induced protection against myocardial infarction during early reperfusion in vivo. Anesth. Analg., May 1, 2006; 102(5): 1348 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wang, D. A. Neff, J. G. Krolikowski, D. Weihrauch, M. Bienengraeber, D. C. Warltier, J. R. Kersten, and P. S. Pagel The influence of B-cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane-induced and ischemic postconditioning in rabbits. Anesth. Analg., May 1, 2006; 102(5): 1355 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Gross and G. J. Gross Ligand triggers of classical preconditioning and postconditioning Cardiovasc Res, May 1, 2006; 70(2): 212 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Gateau-Roesch, L. Argaud, and M. Ovize Mitochondrial permeability transition pore and postconditioning Cardiovasc Res, May 1, 2006; 70(2): 264 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Garcia-Dorado, A. Rodriguez-Sinovas, M. Ruiz-Meana, J. Inserte, L. Agullo, and A. Cabestrero The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion Cardiovasc Res, May 1, 2006; 70(2): 274 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Krolikowski, D. Weihrauch, M. Bienengraeber, J. R. Kersten, D. C. Warltier, and P. S. Pagel Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo: [Le role des Erk1/2, p70s6K et eNOS dans la cardioprotection induite par l'isoflurane pendant la reperfusion in vivo precoce] Can J Anesth, February 1, 2006; 53(2): 174 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Krolikowski, M. Bienengraeber, D. Weihrauch, D. C. Warltier, J. R. Kersten, and P. S. Pagel Inhibition of Mitochondrial Permeability Transition Enhances Isoflurane-Induced Cardioprotection During Early Reperfusion: The Role of Mitochondrial KATP Channels Anesth. Analg., December 1, 2005; 101(6): 1590 - 1596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hedhli, M. Pelat, and C. Depre Protein turnover in cardiac cell growth and survival Cardiovasc Res, November 1, 2005; 68(2): 186 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Younes, S. Pepe, D. Yoshishige, J. L. Caffrey, and E. G. Lakatta Ischemic preconditioning increases the bioavailability of cardiac enkephalins Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1652 - H1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Frassdorf, N. C. Weber, D. Obal, O. Toma, J. Mullenheim, G. Kojda, B. Preckel, and W. Schlack Morphine Induces Late Cardioprotection in Rat Hearts In Vivo: The Involvement of Opioid Receptors and Nuclear Transcription Factor {kappa}B Anesth. Analg., October 1, 2005; 101(4): 934 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Weihrauch, J. G. Krolikowski, M. Bienengraeber, J. R. Kersten, D. C. Warltier, and P. S. Pagel Morphine Enhances Isoflurane-Induced Postconditioning Against Myocardial Infarction: The Role of Phosphatidylinositol-3-Kinase and Opioid Receptors in Rabbits Anesth. Analg., October 1, 2005; 101(4): 942 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Okada, H. Otani, Y. Wu, T. Uchiyama, S. Kyoi, R. Hattori, T. Sumida, H. Fujiwara, and H. Imamura Integrated pharmacological preconditioning and memory of cardioprotection: role of protein kinase C and phosphatidylinositol 3-kinase Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H761 - H767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tsang, D. J. Hausenloy, and D. M. Yellon Myocardial postconditioning: reperfusion injury revisited Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H2 - H7. [Full Text] [PDF]
|
|
|
|
|
|
C. J. Zuurbier, O. Eerbeek, and A. J. Meijer Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H496 - H499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Gross, J. N. Peart, A. K. Hsu, J. A. Auchampach, and G. J. Gross Extending the cardioprotective window using a novel {delta}-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2744 - H2749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Cao, L. Liu, and D. M. Van Winkle Met5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1955 - H1964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dong, J. Peng, H. Zhang, W. H. Mondesire, W. Jian, G. B. Mills, M.-C. Hung, and F. Meric-Bernstam Role of Glycogen Synthase Kinase 3{beta} in Rapamycin-Mediated Cell Cycle Regulation and Chemosensitivity Cancer Res., March 1, 2005; 65(5): 1961 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nithipatikom, E. R. Gross, M. P. Endsley, J. M. Moore, M. A. Isbell, J. R. Falck, W. B. Campbell, and G. J. Gross Inhibition of Cytochrome P450{omega}-Hydroxylase: A Novel Endogenous Cardioprotective Pathway Circ. Res., October 15, 2004; 95(8): e65 - e71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pepe, O. W.V van den Brink, E. G Lakatta, and R.-P. Xiao Cross-talk of opioid peptide receptor and {beta}-adrenergic receptor signalling in the heart Cardiovasc Res, August 15, 2004; 63(3): 414 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Gross, A. K. Hsu, and G. J. Gross Acute Aspirin Treatment Abolishes, whereas Acute Ibuprofen Treatment Enhances Morphine-Induced Cardioprotection: Role of 12-Lipoxygenase J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 185 - 191. [Abstract] [Full Text] [PDF]
|
|